These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 16194456)

  • 41. Insights into the management of patients with primary central nervous system lymphoma.
    Fox CP
    Clin Adv Hematol Oncol; 2022 Apr; 20(4):203-207. PubMed ID: 35389383
    [No Abstract]   [Full Text] [Related]  

  • 42. Prognostic implication of p27 expression in primary central nervous system lymphoma.
    Kunishio K; Nagao S
    Brain Tumor Pathol; 2006 Oct; 23(2):77-81. PubMed ID: 18095123
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differentiating primary central nervous system (CNS) lymphoma from "butterfly glioma": A case report.
    Bragin A; Safouris A; Bourgonjon B; Michotte A; Triantafyllou N; Tsivgoulis G
    J Neurol Sci; 2015 Jul; 354(1-2):114-5. PubMed ID: 25982183
    [No Abstract]   [Full Text] [Related]  

  • 44. Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year national survey.
    Haldorsen IS; Krossnes BK; Aarseth JH; Scheie D; Johannesen TB; Mella O; Espeland A
    Cancer; 2007 Oct; 110(8):1803-14. PubMed ID: 17721992
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primary hepatic lymphoma: features of a puzzling disease.
    Chahdi Beltrame M; De Santibañes M; Ardiles V; Mazza O; Pekolj J; De Santibañes E; Sánchez Clariá R
    J Gastrointest Cancer; 2015 Jun; 46(2):178-81. PubMed ID: 25701299
    [No Abstract]   [Full Text] [Related]  

  • 46. Primary lymphoma of the central nervous system: epidemiology, pathology and current approaches to diagnosis, prognosis and treatment.
    Rubenstein J; Ferreri AJ; Pittaluga S
    Leuk Lymphoma; 2008; 49 Suppl 1(0 1):43-51. PubMed ID: 18821432
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Malignant lymphoma of the testis.
    Doll DC; Weiss RB
    Am J Med; 1986 Sep; 81(3):515-24. PubMed ID: 3529957
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options.
    Ferreri AJ; Assanelli A; Crocchiolo R; Ciceri F
    Hematol Oncol; 2009 Jun; 27(2):61-70. PubMed ID: 19247977
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary CNS plasmablastic lymphoma in an HIV/EBV negative patient: A case report.
    Romero M; González-Fontal GR; Saavedra C; Guerra J; Quintero G; Quijano S; Ney D; Henao-Martínez AF
    Diagn Cytopathol; 2016 Jan; 44(1):61-5. PubMed ID: 26468050
    [No Abstract]   [Full Text] [Related]  

  • 50. [A retrospective analysis of 8 cases with primary central nervous system lymphoma].
    Zhou XQ; Liu XQ; Kong JC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Oct; 23(5):455-7. PubMed ID: 12905861
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group.
    Kasenda B; Ihorst G; Schroers R; Korfel A; Schmidt-Wolf I; Egerer G; von Baumgarten L; Röth A; Bloehdorn J; Möhle R; Binder M; Keller U; Lamprecht M; Pfreundschuh M; Valk E; Fricker H; Schorb E; Fritsch K; Finke J; Illerhaus G
    Leukemia; 2017 Dec; 31(12):2623-2629. PubMed ID: 28559537
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Primary central nervous system lymphoma.
    Gallop-Evans E
    Clin Oncol (R Coll Radiol); 2012 Jun; 24(5):329-38. PubMed ID: 22459053
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Primary central nervous system lymphomas: incidence and survival in the Southern and Eastern Netherlands.
    van der Sanden GA; Schouten LJ; van Dijck JA; van Andel JP; van der Maazen RW; Coebergh JW;
    Cancer; 2002 Mar; 94(5):1548-56. PubMed ID: 11920513
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary central nervous system lymphoma and subcutaneous metastases.
    Al Bahrani B; Henderson C; Delaney G
    J Neurooncol; 2000 Apr; 47(2):141-4. PubMed ID: 10982155
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combination immunotherapy as a non-chemotherapy alternative for refractory or recurrent CNS lymphoma.
    Ambady P; Szidonya L; Firkins J; James J; Johansson K; White T; Jezierski C; Doolittle ND; Neuwelt EA
    Leuk Lymphoma; 2019 Feb; 60(2):515-518. PubMed ID: 30033836
    [No Abstract]   [Full Text] [Related]  

  • 56. Primary central nervous system lymphoma: recent progress, many remaining questions.
    Swinnen LJ
    Curr Opin Oncol; 2009 Sep; 21(5):393-6. PubMed ID: 19593137
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of secondary central nervous system lymphoma.
    Cwynarski K; Cummin T; Osborne W; Lewis J; Chaganti S; Smith J; Linton K; Greaves P; McKay P; Fox CP;
    Br J Haematol; 2023 Jan; 200(2):160-169. PubMed ID: 36408800
    [No Abstract]   [Full Text] [Related]  

  • 58. New therapies of primary CNS lymphomas and oligodendrogliomas.
    Macdonald DR
    J Neurooncol; 1995; 24(1):97-101. PubMed ID: 8523084
    [No Abstract]   [Full Text] [Related]  

  • 59. Unusual uterine recurrence of primary central nervous system lymphoma.
    Nichols GL; Jacobson CA; Ferman D; Lichtman SM
    Clin Adv Hematol Oncol; 2006 Sep; 4(9):697-8, discussion 699-700. PubMed ID: 17099627
    [No Abstract]   [Full Text] [Related]  

  • 60. CNS leukemia: problem of diagnosis, treatment, and outcome.
    Steinherz PG
    J Clin Oncol; 1995 Feb; 13(2):310-3. PubMed ID: 7844591
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.